Hsp90 protein helps to target cancer tumours

被引：0
|
作者：
不详
机构：
来源：
CHEMISTRY & INDUSTRY | 2003年 / 19期
关键词：
D O I：
暂无
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [21] Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
    Park, Sangkyu
    Park, Jeong-A
    Jeon, Jae-Hyung
    Lee, Younghee
    BIOMOLECULES & THERAPEUTICS, 2019, 27 (05) : 423 - 434
  • [22] The network interaction of the human cytosolic 90 kDa heat shock protein Hsp90: A target for cancer therapeutics
    da Silva, Viviane C. H.
    Ramos, Carlos H. I.
    JOURNAL OF PROTEOMICS, 2012, 75 (10) : 2790 - 2802
  • [23] Role of HSP90 in Cancer
    Birbo, Bereket
    Madu, Elechi E.
    Madu, Chikezie O.
    Jain, Aayush
    Lu, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [24] HSP90 and the chaperoning of cancer
    Whitesell, L
    Lindquist, SL
    NATURE REVIEWS CANCER, 2005, 5 (10) : 761 - 772
  • [25] HSP90 and the chaperoning of cancer
    Luke Whitesell
    Susan L. Lindquist
    Nature Reviews Cancer, 2005, 5 : 761 - 772
  • [26] The Hsp90 chaperone complex-A potential target for cancer therapy?
    Beatrice D. Darimont
    World Journal of Gastroenterology, 1999, (03) : 195 - 198
  • [27] Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors
    Haginaka, Jun
    Kitabatake, Tomoko
    Hirose, Iyo
    Matsunaga, Hisami
    Moaddel, Ruin
    ANALYTICAL BIOCHEMISTRY, 2013, 434 (01) : 202 - 206
  • [28] HSP90 as a new therapeutic target for cancer therapy: the story unfolds
    Maloney, A
    Workman, P
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) : 3 - 24
  • [29] Hsp90 inhibitors target addiction to mutant oncoproteins in colorectal cancer
    Clarke, P. A.
    Welsh, L.
    Valenti, M.
    Eccles, S.
    Workman, P.
    EJC SUPPLEMENTS, 2008, 6 (12): : 47 - 47
  • [30] HSP90: A promising target for NSCLC treatments
    Zhu, Yue
    Dai, Zhaoxia
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 967
12345